Clinical Trial Update: Using Glialia for Treating Persistent Perceptual Postural Dizziness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Glialia in treating persistent postural perceptual dizziness, currently recruiting in Italy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Postural-perceptual Dizziness

Drugs mentioned

• Glialia

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Persistent Postural Perceptual Dizziness | Phase 4 | Status: RECRUITING